This study is currently not recruiting participants.

VX-770 Expanded Access Program (EAP)

Access to Investigational Medication

Not Recruiting
18 years - 100 years
All
Phase N/A

Brief description of study.

The purpose of this study is to allow patients access to VX-770.

Detailed description of study

The purpose of this study is to allow patients access to VX-770.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Cystic Fibrosis
  • Age: 18 years - 100 years
  • Gender: All

The purpose of this study is to allow patients access to an investigational medication.

Participants will receive the investigational medication according to the study procedures.

  • Who can participate: Include criteria such as age range 18-65, diagnosis of the specific condition under study, and other relevant eligibility factors.
  • Study details: Participants will receive an investigational medication as part of the study.
Updated on 19 Feb 2024. Study ID: 1108006492

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team